Sangamo BioSciences | SGMO - Nettoeinkommen

Aktienkurs
0.32
Täglich Wechseln
-0.01 -2.05%
Monatlich
-31.24%
Jährlich
-62.66%
Q1 Prognose
0.32




Nettoeinkommen Veränderung Datum
Alaunos Therapeutics USD -1.16M 108K 2025-09
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Amgen USD 1.33B 1.88B 2025-12
Bayer EUR -3.76B 2.79B 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD 56.84M 63.82M 2025-12
CSL USD 401M 96.5M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
J&J USD 5.12B 36M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Tectonic Therapeutic USD -19.23M 186K 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12